08/07/2025
7:09 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
7:06 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2025
4:55 PM | Baum Bryan Daniel (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/21/2025
4:56 PM | Baum Bryan Daniel (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
7:56 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
3:02 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2025
6:53 PM | COOPERSTONE BRENDA (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:53 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:55 PM | Hsiung Feng (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:55 PM | Collins James J. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2025
6:51 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SNTI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
06/27/2025
6:02 PM | Mathers Edward T (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
6:05 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
3:41 PM | Nantahala Capital Management, LLC (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
3:43 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13G/A | |
05/06/2025
3:42 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
3:48 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
4:25 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form ARS | |
04/28/2025
6:12 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
11:15 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form EFFECT | |
03/31/2025
11:15 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form EFFECT | |
03/24/2025
5:02 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
5:12 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/21/2025
5:06 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/20/2025
3:21 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
5:35 PM | BAYER HEALTHCARE LLC (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13D | |
03/17/2025
2:01 PM | Celadon Partners SPV 24 (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13D/A | |
03/14/2025
10:52 AM | Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:32 PM | Celadon Partners SPV 24 (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
8:30 PM | BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
8:20 PM | BASKETT FOREST (Reporting)
Florence Anthony A. Jr. (Reporting)
Makhzoumi Mohamad (Reporting)
NEA 15 GP, LLC (Reporting)
NEA Partners 15, L.P. (Reporting)
New Enterprise Associates 15, L.P. (Reporting)
SANDELL SCOTT D (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
7:31 PM | BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:17 PM | Hsiung Feng (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:20 PM | COOPERSTONE BRENDA (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:20 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:20 PM | Collins James J. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:21 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:23 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
6:00 PM | New Enterprise Associates 15, L.P. (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13D/A | |
03/10/2025
6:01 PM | Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
6:02 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Out of 18,347 Cryptocurrencies... This is the ONLY One (Ad) The Single Most Undervalued DeFi Protocol You've Never Heard Of
If there's one cryptocurrency you should buy in this market, this token might just be it. Get the whole story on this "crypto market unicorn" right here. |
03/07/2025
4:18 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
4:19 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
3:31 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:23 PM | Lu Timothy K (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
6:53 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:30 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
6:30 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form DEF 14A | |
01/15/2025
3:15 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form PRE 14A | |
12/19/2024
3:34 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/16/2024
3:09 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
6:38 PM | BAYER AKTIENGESELLSCHAFT (Reporting)
BAYER HEALTHCARE LLC (Reporting)
Bayer US Holding LP (Reporting)
Bayer World Investments B.V. (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:15 PM | Rajangam Kanya (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:16 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/10/2024
3:17 PM | Schulz Fran (Reporting)
Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:18 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/10/2024
3:19 PM | Senti Biosciences, Inc. (Issuer)
Senti Biosciences (Issuer)
Tang Donald F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:18 PM | Farokhzad Omid (Reporting)
Senti Biosciences, Inc. (Subject)
Senti Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:02 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
7:26 AM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:51 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
3:32 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:05 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:42 PM | Senti Biosciences, Inc. (Filer)
Senti Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access